Hainan Huluwa Pharmaceutical Group Co Ltd
605199
Company Profile
Business description
Hainan Huluwa Pharmaceutical Group Co Ltd is engaged in production and sales of Chinese patent medicines and chemical drugs. The company produces medicines for children's respiratory and digestive systems. Its products include star products, calabash, gourd dad, and gourd mom.
Contact
No. 8, Yaogu 4th Road, Phase II
Yaogu Industrial Park
Haikou National High-tech Zone
Hainan Province
Haikou570300
CHNT: +86 8986868976
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
2,103
Stocks News & Analysis
stocks
Cheapest ASX member of our Best Idea’s list
This share is trading at the lowest price to fair value of the 14 companies on the list.
stocks
We remove our Moat Rating from ASX listed share
Despite a surging share price a weakening competitive position causes a reassessment of our view.
stocks
Best sustainable companies to own in 2026
We believe these companies’ strong ESG management practices give them a long-term advantage.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,996.90 | 78.80 | -0.87% |
| CAC 40 | 8,216.51 | 5.01 | 0.06% |
| DAX 40 | 24,934.61 | 65.92 | 0.27% |
| Dow JONES (US) | 48,978.20 | 1.02 | 0.00% |
| FTSE 100 | 10,121.40 | 116.83 | 1.17% |
| HKSE | 26,710.45 | 363.21 | 1.38% |
| NASDAQ | 23,450.14 | 54.32 | 0.23% |
| Nikkei 225 | 52,518.08 | 685.28 | 1.32% |
| NZX 50 Index | 13,663.58 | 76.35 | 0.56% |
| S&P 500 | 6,911.79 | 9.74 | 0.14% |
| S&P/ASX 200 | 8,682.80 | 88.50 | -1.01% |
| SSE Composite Index | 4,083.67 | 60.25 | 1.50% |